504Your membership is currently disabled from accessing the online portal. Please contact the office to resolve this issue.

Rescheduling of cannabidiol (CBD) in the Australian Poisons Standard (SUSMP)

There has been considerable public interest in using the cannabis plant for medicinal purposes, both in Australia, and internationally. Of particular interest has been cannabidiol (CBD), a phytochemical constituent of Cannabis spp., which confers many of the therapeutic actions of cannabis, including its use in central nervous system disorders such as epilepsy, pain management, nausea, cancer, and immunological disorders (Pisanti et al., 2017).